← Back to Search

GLP-1 Receptor Agonist

Active drug for Bipolar Disorder

Phase 2

Waitlist Available

Research Sponsored by Lindner Center of HOPE

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 40 week

Awards & highlights

Study Summary

This trial will test whether liraglutide, a medication used to treat diabetes, can help reduce weight and improve metabolism in obese or overweight patients with bipolar disorder without worsening psychiatric symptoms.

Eligible Conditions

Bipolar Disorder
Obesity

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 40 week

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~40 week

This trial's timeline: 3 weeks for screening, Varies for treatment, and 40 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent Change in Body Weight

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Active drugActive Control1 Intervention

LIRAGLUTIDE 3 Mg/0.5 mL (18 Mg/3 mL) SUB-Q PEN INJECTOR (ML)

Group II: PlaceboPlacebo Group1 Intervention

Placebo (no active drug)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lindner Center of HOPELead Sponsor

28 Previous Clinical Trials

1,335 Total Patients Enrolled

9 Trials studying Bipolar Disorder

556 Patients Enrolled for Bipolar Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are being included in this clinical research project?

"At the moment, this particular trial is not enrolling patients. However, it was first posted on 4/26/2017 and last updated on 5/24/2022. There are presently 1353 studies actively looking for patients with manic disorder and 36 trials for Active drug actively enrolling participants."

Answered by AI

How is Active drug most commonly used?

"Active drug is most commonly used to treat exercise, but it can also be helpful for patients that have inadequate control on monotherapy or suffer from cardiovascular disease."

Answered by AI

What are the dangers of Active drug for patients?

"Active drug received a score of 2 because, while Phase 2 trials offer some data supporting safety, there is none for efficacy."

Answered by AI

If a patient is below the age of 45, can they still participate in this trial?

"This particular trial is only open to patients aged 18-65. There are 259 other trials for patients that fall under the age of 18 and 871 trials for seniors above the age of 65."

Answered by AI

Are there any inclusionary criteria for this experiment?

"The age limit for participants is 65 years old and the minimum age requirement is 18 years old. This trial will have a total of 60 people who suffer from manic disorder."

Answered by AI

Are there still positions available for participants in this research project?

"Unfortunately, this study is no longer looking for participants. The listing was first created on April 26th, 2017 and updated for the last time on May 24th, 2022. If you are still interested in finding trials, there are 1353 other studies actively searching for patients with manic disorder and 36 studies involving active drugs that are currently enrolling patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)

Susan McElroy 2017. "Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03158805.